14Mar 2025
Semaglutide 2.4 mg vs Placebo for Weight Management in Adults

Semaglutide 2.4 mg vs Placebo for Weight Management in Adults

Semaglutide 2.4 mg significantly reduces body weight in adults with overweight or obesity. In a phase 3a trial, semaglutide showed a mean weight loss of 11.8%, compared to 3.5% with placebo. Additionally, 85.4% of participants on semaglutide achieved ≥5% weight loss, compared to 26.8% on placebo. While gastrointestinal issues were common, the findings support semaglutide as an effective treatment for weight management in this population.

  • #endo-diabetology

Like

Save

Share